Peter Heerma
Chief Commercial Officer at Travere Therapeutics, Inc. (TVTX); Evp, Chief Commercial Officer at Travere Therapeutics, Inc. (TVTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 71,938147,318 held (−33%) | $62.05 | $4.5M | -16.0% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 27,421119,897 held (−19%) | $62.59 | $1.7M | -16.7% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 1,400118,497 held (−1%) | $63.65 | $89K | -18.1% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 1,431117,066 held (−1%) | $65.31 | $93K | -20.2% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 93,604196,179 held (−32%) | $63.25 | $5.9M | -17.6% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 79,113117,066 held (−40%) | $63.65 | $5.0M | -18.1% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 8,282117,066 held (−7%) | $65.07 | $539K | -19.9% |
| May 6SEC | TVTXTravere Therapeutics, Inc. | Sell | 2,174140,684 held (−2%) | $46.65 | $101K | +11.7% |
| Apr 15SEC | TVTXTravere Therapeutics, Inc. | Sell | 7,215138,608 held (−5%) | $41.93 | $303K | +24.3% |
| Feb 3SEC | TVTXTravere Therapeutics, Inc. | Sell | 7,310131,823 held (−5%) | $32.12 | $235K | +62.3% |
| Dec 29SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 4,980113,013 held (−4%) | $40.00 | $199K | +30.3% |
| Nov 4SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 5,591119,071 held (−4%) | $35.00 | $196K | +48.9% |
| Oct 30SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 2,662124,662 held (−2%) | $30.00 | $80K | +73.8% |
- Sell
Evp, Chief Commercial Officer Peter Heerma sold $4.5M of TVTX at $62.05 — cuts the stake by 33%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Commercial Officer Peter Heerma sold $1.7M of TVTX at $62.59 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Commercial Officer Peter Heerma sold $89K of TVTX at $63.65 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Commercial Officer Peter Heerma sold $93K of TVTX at $65.31 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Commercial Officer Peter Heerma sold $5.9M of TVTX at $63.25 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Commercial Officer Peter Heerma sold $5.0M of TVTX at $63.65 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.